This is a quarterly newsletter of recent developments in Korean intellectual property laws and policies from Kim & Chang.
This issue includes:
PATENT
- Korean District Court Recognizes Infringement of Pfizer's Patent for Prevenar 13® Based on Extraterritorial Activity
- KIPO Clarifies Written Description Requirements for Cosmetic Inventions
- Expedited Examination for Display Patent Applications Now Available
- Changes to Korea's Expedited Examination System and Patent Term Adjustment Practices in 2024
TRADEMARK, DESIGN & UNFAIR COMPETITION
- Supreme Court Issues Landmark Decision on the Criteria for Dilution Under the Trademark Act
- A Letter of Consent System Is Among the Notable Amendments to the Korean Trademark Act Coming Into Effect in 2024
- KIPO SJP's Investigative Authority to be Further Expanded
- New Applicant-Friendly Amendments to the Design Protection Act
- Expedited Examination of Korean Trademark Applications Has Become More Difficult Post-January 1, 2024
To view the newsletter, please click here or download the attachment.
Attachments KIM & CHANG IP Newsletter_2023 Issue 4.pdf
Related Topics
